共 88 条
[1]
Dasari A(2017)Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States JAMA Oncology 3 1335-1342
[2]
Shen C(2004)Epidemiology of Neuroendocrine Tumours Neuroendocrinology 80 3-7
[3]
Halperin D(2020)The 2019 WHO classification of tumours of the digestive system Histopathology 76 182-188
[4]
Zhao B(1997)Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours European Journal of Clinical Investigation 27 639-644
[5]
Zhou S(2011)Standard Imaging Techniques for Neuroendocrine Tumors Endocrinology and Metabolism Clinics of North America 40 153-162
[6]
Xu Y(2017)Impact of liver and wholebody diffusion-weighted MRI for neuroendocrine tumors on patient management: a pilot study Neuroendocrinology 104 264-272
[7]
Shih T(2013)Somatostatin receptor PET/CT in neuroendocrine tumours: Update on systematic review and meta-analysis European Journal of Nuclear Medicine and Molecular Imaging 40 1770-1780
[8]
Yao JC(2007)Imaging of liver metastases: MRI Cancer Imaging 7 2-9
[9]
Taal BG(2014)MRI with Gadoxetate Disodium for Colorectal Liver Metastasis: Is It the New “Imaging Modality of Choice”? Journal of Gastrointestinal Surgery 18 2130-2135
[10]
Visser O(2015)Somatostatin receptor imaging with68Ga DOTATATE PET/CT: Clinical utility, normal patterns, pearls, and pitfalls in interpretation1 Radiographics 35 500-516